Table I.
Demographic and clinical characteristics of patients
| Parameter | Patients | Drug-responsive | Drug-resistant | P-value |
|---|---|---|---|---|
| Gender, n (%): | 0.486 | |||
| Females | 101 (50.5) | 68 (52.3) | 33 (47.1) | |
| Males | 99 (49.5) | 62 (47.7) | 37 (52.9) | |
| Age, mean ± SD [years] | 41.74 ±16.50 | 40.76 ±16.55 | 43.56 ±16.37 | 0.254 |
| Type of epilepsy, n (%): | < 0.001 | |||
| Idiopathic generalized | 56 (28.0) | 55 (42.3) | 1 (1.4) | |
| Symptomatic generalized | 9 (4.5) | 7 (5.4) | 2 (2.9) | |
| Symptomatic partial | 69 (34.5) | 44 (33.8) | 25 (35.7) | |
| Cryptogenic partial | 66 (33.0) | 24 (18.5) | 42 (60.0) | |
| Drug response | 130 (65.0) | 70 (35.0) | ||
| Therapy, n (%): | ||||
| Monotherapy minimum doses | 37 (18.5) | |||
| Monotherapy maximum doses | 58 (29.0) | |||
| Polytherapy | 105 (52.5) |